Advertisement

The clinical significance of pituitary-adrenal suppression by exogenous corticosteroids

      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Clinical Epidemiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Ragan C
        Corticotropin, cortisone and related steroids in clinical medicine: practical considerations.
        Bull NY Acad Med. 1953; 29: 355
        • Janoski AH
        • Shaver JC
        • Christy NP
        • Rosner W
        On the pharmacologic properties of 21-carbon hormonal steroids (‘glucocorticoids’) in mammals.
        in: Handbuch der experimentellen Pharmakologie. Vol. 14. Springer, Berlin1968: 256 (part 3)
        • David DS
        • Grieco MH
        • Cushing Jr, P
        Adrenal glucocorticoids after twenty years.
        J Chron Dis. 1970; 22: 637
        • Baxter JD
        • Rousseau GG
        • Higgins SJ
        • Tomkins GM
        Molecular basis of glucocorticoid response: specific DNA binding of a steroid-receptor complex.
        J clin Invest. 1972; 51: 9a
        • Christy NP
        Iatrogenic Cushing's Syndrome.
        in: Christy NP The Human Adrenal Cortex. Harper & Row, New York1971: 395
        • Salassa RM
        • Bennett WA
        • Keating Jr, FR
        Sprague RG: Postoperative adrenal cortical insufficiency: occurrence in patients previously treated with cortisone.
        J Am Med Ass. 1953; 152: 1509
        • Cope CL
        The adrenal cortex in internal medicine.
        Brit med J. 1966; 2: 847
        • Danowski TS
        • Bonessi JV
        • Sabeh G
        • Sutton RD
        • Webster Jr, MV
        • Sarver ME
        Probabilities of pituitary-adrenal responsiveness after steroid therapy.
        Ann intern Med. 1964; 61: 11
        • Allanby KD
        Deaths associated with Steroid Hormone Therapy: An analysis of 18 cases.
        Lancet. 1957; 1: 1104
        • Jasani MK
        • Freeman PA
        • Boyle JA
        • Reid AM
        • Diver MJ
        • Buchanan WW
        Studies of the rise in plasma 11-hydroxycorticosteroids (11-OHCS) in corticosteroid-treated patients with rheumatoid arthritis during surgery: correlations with the functional integrity of the hypothalmo-pituitary-adrenal axis.
        Quart J Med. 1968; 37: 147
        • Graber AL
        • Ney RL
        • Nicholson WE
        • Island DP
        • Liddle GW
        Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids.
        J clin Endocrin. 1965; 25: 11
        • Hollander MH
        Psychological reactions to cortisone.
        Psychosomat Med. 1952; 14: 306
        • McCawley A
        Cortisone habituation—a clinical note.
        N Engl J Med. 1965; 273: 976
        • Kelly M
        Toxic effects of steroids.
        Lancet. 1964; 2: 415
        • Kelly M
        Steroids: Drugs of addiction to patient and doctor.
        J Chron Dis. 1964; 17: 461
        • Amatruda Jr, TT
        • Hollingsworth DR
        • D'Esopo ND
        • Lipton GV
        • Bondy PK
        A study of the mechanism of the steroid withdrawal syndrome: evidence for the integrity of the hypothalmic-pituitary-adrenal system.
        J clin Endocrin. 1960; 20: 339
        • Amatruda Jr, TT
        • Hurst MD
        • D'Esopo ND
        Certain endocrine and metabolic facets of the steroid withdrawal syndrome.
        J clin Endocrin. 1965; 25: 1207
        • Christy NP
        • Wallace EZ
        • Jailer JW
        The effect of intravenously administered ACTH on plasma 17, 21-dihydroxy-20-ketosteroids in normal individuals and in patients with disorders of the adrenal cortex.
        J clin Invest. 1959; 34: 899
        • Liddle GW
        • Estep HL
        • Kendall Jr, JW
        • Williams Jr, WC
        • Townes AW
        Clinical application of a new test of pituitary reserve.
        J clin Endocrin. 1959; 19: 875
        • Harter JG
        • Reddy WJ
        • Thorn GW
        Studies on an intermittent corticosteroid dosage regimen.
        New Engl J Med. 1963; 269: 592
        • Martin MM
        • Gaboardi F
        • Podolsky S
        • Raiti S
        • Calcagno PL
        Intermittent steroid therapy: its effect on hypothalmic-pituitary-adrenal function and the response of plasma growth hormone and insulin to stimulation.
        New Engl J Med. 1968; 279: 273